J Korean Soc Clin Pharmacol Ther.  2013 Jun;21(1):71-81.

A Study on Current Status of Clinical Trial Pharmacy in Domestic Clinical Trial Institution

• Jang YJ
• Kang W
• Lee J
• Lee HW
• Park MS
• Yoon YR

Abstract

BACKGROUND
There is a lack of research on the status of clinical trial pharmacy and clinical trial pharmacist (CTP) in Korea. This study was aimed to investigate the current status of clinical trial pharmacy and clinical trial pharmacists.
METHODS
The survey was performed using the 41-item questionnaire designed to investigate information on the following; (1) current status of clinical trial pharmacy designated by Korea Food and Drug Administration, (2) current status of working condition, management, and satisfaction index of CTP. Data collected was analyzed by t-test and chi2.
RESULTS
Among the CTPs who responded, 92.7% belonged to department of pharmacy, and 7.3% to clinical trial center. 90.2% of the respondents were women. Forty-two point seven percents of the respondents had more than 3 years of experience in the clinical trial field. 36.6% answered that the current number of CTPs in the institution was '2'. Sixty-three point four percents answered that they subsumed an additional post. Regarding the question on "whether the equipment and working environment of your clinical trials pharmacy is adequate", 65.1% of the respondents answered as 'Inadequate'. Ninety-eight point eight percents answered that work-related education is needed. Ninety-three point nine percents answered that the quality of clinical trials is related to the improvement of the working environment of CTP.
CONCLUSION
Clinical trial pharmacy's facility and number of actually working CTP were insufficient. Proper and continuous education and training for CTPs are needed to improve the quality of clinical trials conducted in Korea, with strong institution support and timely regulation change.

Keyword

Clinical trial pharmacist; Clinical trial pharmacy; Current status; Education

MeSH Terms

Cytidine Triphosphate
Surveys and Questionnaires
Female
Humans
Korea
Pharmacists
Pharmacy
Silanes
United States Food and Drug Administration
Cytidine Triphosphate
Silanes

Figure

• 

  Figure 1. Training and education course of other clinical trial participants.

Reference

1. Kim JY. Study of the improvement and the status of domestic/international clinical trial. Unpublished master’s thesis. Sookmyung Women’s University, Seoul. (Korean).

2. Shin SG. Clinical trials of new drug. Korean Society for Clinical Pharmacology and Therapeutics Spring workshop;2000. p. 30–41. (Korean).

3. Kim TE, Kim KH. Job status and job satisfaction among clinical research coordinator. J Korean Acad Nurs Admin. 2009; 15(3):336–345.

4. Jang IJ. Modanization of Clinical Trial Infrastructure. Kor J Clin Pharmacol Ther. 2006; 14(1):29–32. (Korean).

5. Korea Good Clinical Practice (KGCP). Korea Food and Drug Administration. 2011; (Korean).

6. Durrant KL. Pharmacist’s role in enhancing patient participation in clinical trial research. http://www.cop.ufl.edu/wp-content/uploads/dept/wppd/pc/sample06b.pdf. [Online] (last visited on 05 Nov 2012).

7. Ganachari MS, Soham PS, Nidhi M. Pharmacist: A crucial part of clinical Research. J Pharmacy Research. 2010; 3(3):444–450.

8. Murray J, Foster A, Young J. Survey to investigate the role of the community stroke care coordinator. Br J Community Nurs. 2008; 13(1):31–36.

9. Lee EK, Jang SM, Huh SI. Study on the Clinical Trial Practice of Drugs at the Designated Hospitals. Kor J Clin Pharm. 1995; 5(2):33–50.

10. KoNECT. KoNECT web sites on clinical trial training and education program. http://www.konect.or.kr/html/04_specialty/Specialty_02.action?header=04&sub=04. [Online] (last visited on 06 Nov 2012).

11. La HO, Choi S, Lee SK, Ryu BE, Han OY. Current status and future directions of clinical trials pharmacy. Yakugaku Zasshi. 2011; 131(6):969–975.

12. McDonagh MS, Miller SA, Naden E. Costs and savings of investigational drug services. Am J Health-Syst Pharm. 2000; 57(1):40–43.

13. doate A, Ortega A, Carrera FJ, Aldaz A, Giráldez J. Cost-evaluation model for clinical trials in a hospital pharmacy service. Pharmacy World Sci. 1995; 17(5):172–176.

14. Ministry of Food and Drug Safety. MFDS web sites on News and Notice. http://www.mfds.go.kr/index.do?mid=54&pageNo=1&seq=20161&cmd=v. [Online] (last visited on 04 Apr 2013).